MENU
ARMP
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Armata Pharmaceuticals (ARMP) Ownership - Who owns Armata Pharmaceuticals?
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
5005 McConnell Avenue
Phone
+1 310 665-2928
Employees
66
Web
https://www.armatapharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
72.39M
P/E Ratio
N/A
Total Cash
11.69M
Projected Growth
N/A
Total Debt
134.66M
Revenue
N/A
Risk (Beta)
2.00
Dividend Yield
N/A
Total Cash/Share
0.32
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ARMP
Capitalization
72.4M
P/E Ratio
N/A
Risk (Beta)
2.00
Dividend Yield
N/A
Total Cash
11.7M
Total Cash/Share
0.32
Total Debt
135M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-53.78M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
362K
Current Ratio
0.12
Current Revenue Per Employee
815.79
Dividends Per Share - Security
N/A
EBITDA
13.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-0.41
Shares Held By Institutions
1.68M
Shares Outstanding - Current
36.2M
Total Liabilities
141M
Total Volume MTD
N/A
Value
-1
Gain YTD
8.108
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel bacteriophage-based therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
5005 McConnell Avenue
Phone
+1 310 665-2928
Employees
66
Web
https://www.armatapharma.com